rs61737719

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000093.5(COL5A1):​c.2031G>A​(p.Glu677Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00068 in 1,613,668 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00065 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00068 ( 1 hom. )

Consequence

COL5A1
NM_000093.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.275

Publications

4 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 9-134763734-G-A is Benign according to our data. Variant chr9-134763734-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.275 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00065 (99/152302) while in subpopulation EAS AF = 0.00368 (19/5158). AF 95% confidence interval is 0.00241. There are 0 homozygotes in GnomAd4. There are 47 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 99 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000093.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A1
NM_000093.5
MANE Select
c.2031G>Ap.Glu677Glu
synonymous
Exon 20 of 66NP_000084.3
COL5A1
NM_001278074.1
c.2031G>Ap.Glu677Glu
synonymous
Exon 20 of 66NP_001265003.1P20908-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A1
ENST00000371817.8
TSL:1 MANE Select
c.2031G>Ap.Glu677Glu
synonymous
Exon 20 of 66ENSP00000360882.3P20908-1
COL5A1
ENST00000371820.4
TSL:2
c.2031G>Ap.Glu677Glu
synonymous
Exon 20 of 66ENSP00000360885.4P20908-2
COL5A1
ENST00000950240.1
c.2022G>Ap.Glu674Glu
synonymous
Exon 20 of 66ENSP00000620299.1

Frequencies

GnomAD3 genomes
AF:
0.000651
AC:
99
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00368
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000705
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000713
AC:
179
AN:
250890
AF XY:
0.000633
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00305
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.000680
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000683
AC:
998
AN:
1461366
Hom.:
1
Cov.:
30
AF XY:
0.000633
AC XY:
460
AN XY:
726960
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33472
American (AMR)
AF:
0.000313
AC:
14
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00297
AC:
118
AN:
39692
South Asian (SAS)
AF:
0.000244
AC:
21
AN:
86228
European-Finnish (FIN)
AF:
0.000957
AC:
51
AN:
53276
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.000674
AC:
749
AN:
1111734
Other (OTH)
AF:
0.000630
AC:
38
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.000631
AC XY:
47
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41568
American (AMR)
AF:
0.00111
AC:
17
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00368
AC:
19
AN:
5158
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
68032
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000518
Hom.:
0
Bravo
AF:
0.000733
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
2
Ehlers-Danlos syndrome, classic type, 1 (2)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
Ehlers-Danlos syndrome type 7A (1)
-
-
1
Ehlers-Danlos syndrome, classic type (1)
-
-
1
Ehlers-Danlos syndrome, classic type, 1;C5543412:Fibromuscular dysplasia, multifocal (1)
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)
-
-
1
Fibromuscular dysplasia, multifocal (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
2.4
DANN
Benign
0.49
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737719; hg19: chr9-137655580; API